Table 1.
Choice Reaction Time Results
| Variable | Treatment | T1 | T2 | T3 | T4 | Mean |
|---|---|---|---|---|---|---|
| Single Step Visual (CRV) | PL | 0.97 ± 0.14 | 0.98 ± 0.25 | 0.94 ± 0.11 | 0.92 ± 0.15 | 0.95 ± 0.17 |
| SUP | 0.98 ± 0.23 | 0.93 ± 0.14 | 0.91 ± 0.16 | 0.88 ± 0.12 | 0.93 ± 0.16 | |
| Single Step Audio (CRA) |
PL | 0.98 ± 0.09 | 0.96 ± 0.13 | 0.96 ± 0.11 | 0.95 ± 0.12 | 0.97 ± 0.11 |
| SUP | 0.96 ± 0.10 | 0.91 ± 0.09 | 0.89 ± 0.07 | 0.92 ± 0.11 | 0.92 ± 0.10† | |
| Stationary 15 s (CRS15) |
PL | 0.54 ± 0.04 | 0.54 ± 0.07 | 0.56 ± 0.09 | 0.55 ± 0.08 | 0.55 ± 0.07 |
| SUP | 0.56 ± 0.06 | 0.51 ± 0.05 | 0.51 ± 0.06 | 0.51 ± 0.06 | 0.52 ± 0.06 | |
| Lateral 15 s (CRL15) | PL | 0.91 ± 0.11 | 0.91 ± 0.15 | 0.95 ± 0.11 | 0.89 ± 0.13 | 0.91 ± 0.13 |
| SUP | 0.93 ± 0.11 | 0.86 ± 0.07 | 0.88 ± 0.11 | 0.89 ± 0.12 | 0.89 ± 0.10 | |
| Multi-directional 15 s (CRM15) | PL | 1.08 ± 0.10 | 1.13 ± 0.17 | 1.19 ± 0.14 | 1.10 ± 0.12 | 1.13 ± 0.14 |
| SUP | 1.07 ± 0.09 | 1.09 ± 0.10 | 1.03 ± 0.11‡ | 1.09 ± 0.16 | 1.07 ± 0.12† | |
| Stationary 30s (CRS30) | PL | 0.56 ± 0.07 | 0.55 ± 0.09 | 0.54 ± 0.09 | 0.54 ± 0.07 | 0.55 ± 0.08 |
| SUP | 0.55 ± 0.05 | 0.52 ± 0.07 | 0.52 ± 0.06 | 0.52 ± 0.07 | 0.53 ± 0.06 | |
| Lateral 30s (CRL30) | PL | 0.89 ± 0.10 | 0.93 ± 0.13 | 0.92 ± 0.10 | 0.93 ± 0.15 | 0.92 ± 0.12 |
| SUP | 0.91 ± 0.10 | 0.91 ± 0.11 | 0.87 ± 0.12 | 0.90 ± 0.10 | 0.90 ± 0.11 | |
| Multi-directional 30s (CRM30) | PL | 1.15 ± 0.13 | 1.16 ± 0.12 | 1.11 ± 0.15 | 1.15 ± 0.12 | 1.14 ± 0.13 |
| SUP | 1.11 ± 0.10 | 1.10 ± 0.12 | 1.06 ± 0.12 | 1.12 ± 0.12 | 1.10 ± 0.11† | |
| Stick Hits (2 min) | PL | 63 ± 11 | 67 ± 10 | 63 ± 11 | 61 ± 12 | 63 ± 11 |
| SUP | 66 ± 7 | 70 ± 10 | 65 ± 11 | 65 ± 12 | 66 ± 10 | |
PL placebo; SUP supplement; T time point; † = significant main effect for supplement, p < 0.05; ‡ = significant interaction between time and supplement, p < 0.05; All data are reported as mean ± standard deviation.